All Articles

Ora, ophthalmic leader, deepens European foothold as part of Global expansion
Come visit Ora at booth #2131 or set up a meeting with us to learn about how we can help bring your product from concept to approval.
Taking a fresh look at up-to-the-minute treatment modalities for managing patients’ symptoms
Results of the first phase 3 trial were announced.
Antioxidants’ effects on harmful reactive oxygen species may be helpful in the fight against dry eye.
In this installment, we review another innovative project, exploring the progression of a product's development, starting with the initial germination of the idea based on clinical observations.
A look at the attributes of perennial allergy and therapies designed to combat the chronic inflammation it engenders.
Many efforts are under way to improve drug delivery to the back of the eye.
A look at neuropathic pain and its relationship to dry-eye diagnosis and therapeutic strategies.

Pages